Progyny holder proposes $2.71M common share sale
The notice traces the shares to vested restricted and performance stock units and Employee Stock Purchase Plan acquisitions from January 1, 2022, through March 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Progyny, Inc. (PGNY) is named as issuer in a notice for a proposed sale of 90,000 common shares for the account of Anevski 2026 South Dakota NGCG, with an aggregate market value of $2,709,000. The approximate sale date is November 5, 2026. The notice says the shares were acquired upon vesting of restricted stock units and performance stock units and through the Employee Stock Purchase Plan during January 1, 2022, through March 3, 2026. Peter Anevski signed the notice.
Key Figures
Key Terms
Restricted Stock Units financial
Performance Stock Units financial
Employee Stock Purchase Plan financial
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.